Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
piggyBac transposable element derived 4 pseudogene 2 (PGBD4P2) is a non-protein-coding pseudogene in humans, categorized as a processed pseudogene related to transposable element fragments. It is transcribed at low levels in normal tissues but shows increased expression in some types of cancer, including bladder cancer, where research indicates it may promote cell proliferation and migration. Its sequence includes regions highly homologous to its functional parental gene (PA2G4/EBP1) and unique regions, suggesting possible regulatory roles. However, PGBD4P2 does not encode a functional protein and is not recognized as a bona fide therapeutic target such as a receptor or enzyme. It may serve as a potential biomarker or future research candidate for cancer diagnostics, but there are currently no drugs known to interact with this locus[1][2][3][5][6][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on piggyBac transposable element derived 4 pseudogene 2 (PGBD4P2).